The Excerpt cover image

SPECIAL | Why Americans are making homegrown GLP-1s

The Excerpt

00:00

Why Affordable FDA‑Approved Options Haven't Emerged

Dana asks why affordable FDA-approved options aren't available and Nicole discusses demand, supply constraints, and expanding clinical uses.

Play episode from 02:19
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app